You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 1, JANUARY 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Carbonic Anhydrase Inhibition and Cerebral Venous Blood Gases and Ions in Man

Demonstration of Increased Oxygen Availability to Ischemic Brain

FUMIO GOTOH, MD; JOHN S. MEYER, MD; MINORU TOMITA, MD

Arch Intern Med. 1966;117(1):39-46.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

INCREASES of the carbon dioxide tension of brain tissue and cerebral blood flow (CBF) were found to follow administration of acetazolamide (Diamox) in the monkey.1,2 Apparently acetazolamide interfered with carbon dioxide transport by cerebral venous blood with accumulation of carbon dioxide in brain tissue. Reports that CBF increased in man following acetazolamide have been reported by Posner and Plum,3 and Ehrenreich et al.4 Several important questions relevant to its therapeutic use in man remain unsettled.

  1. Does carbon dioxide accumulate in the human brain as it does in animals after acetazolamide administration?
  2. How rapidly does cerebral blood flow increase in man after acetazolamide administration and for how long?
  3. Is oxygen supply to the ischemic human brain affected by cerebral arteriosclerosis increased by acetazolamide?
  4. What are the mechanisms by which human cerebral blood flow becomes increased?
  5. Is there any relationship between increased CBF and the acidosis produced by acetazolamide?
. . . [Full Text PDF of this Article]


Author Affiliations

DETROIT

From the Departments of Neurology, Wayne State University, Detroit Receiving Hospital, and the Wayne Center for Cerebrovascular Research, Harper Hospital, Detroit, and the Department of Internal Medicine, Keio University, Tokyo.


Footnotes

Received for publication June 3, 1965; accepted Aug 26, 1965.

Reprint requests to Department of Neurology, Harper Hospital, 3825 Brush St, Detroit 48210 (Dr. Meyer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.